CHENG, Sainan et al. Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: A prospective CMR study. Radiology and Oncology, [S. l.], v. 59, n. 4, p. 510–521, 2025. Disponível em: https://www.radioloncol.com/index.php/ro/article/view/4626. Acesso em: 17 apr. 2026.